The Alkermes Commercial Learning and Leadership Development (CL&LD) team is looking for someone who will lead the development of field training programs supporting Alkermes’ growing portfolio of mental health treatments. The successful candidate will be responsible for the full portfolio of Alkermes promoted products and Commercial field teams. This position is ideal for someone who enjoys working in an entrepreneurial environment creating impactful, world class training programs that support sales force effectiveness.
Alkermes has recently adopted a hybrid working environment to support and meet the needs of employees and this role will operate in a flexible environment with 60% of time in the office and 40% from home.
Key Duties:
Curriculum / Workshop Development
Deliver and evaluate training programs, curricula, and training materials for field representatives, account managers and field management
Facilitation
Organize and facilitate field training programs, meetings (National & Regional) and the delivery of new materials
Conduct training workshops on disease states, products, marketplaces, and contextual selling skills for all types of audiences
Internal Communication and Influence
Prepare and deliver polished presentations in team setting and with upper management
Represent department on projects
Implement tactical direction of team projects
Communicate with marketing, field leadership, and other key stakeholders to identify training requirements and develop specific training programs to achieve business objectives
Copy Clearance Committee (CCC) Support
Learn CCC process and attend all respective CCC planning meetings
Track and maintain content, including content expiration
Partner with other departments to support CCC process approval, as needed
Vendor / Contract Management
Support the identification, selection and day-to-day management of vendors as well as existing relationships and projects relating to field training (SOW and PO generation and vendor management)
Teamwork & Collaboration
Establish solid relationships with internal and external contact at all levels
Navigate organizational network proficiently
Contribute effectively in team and cross-functional meetings
Budget Management
Accountable for travel & expenses (T&E) and specific project-based budget as assigned
Manager Minimum Education & Experience Requirements:
Bachelor's degree
8+ years of pharmaceutical/biotech/medical device sales experience, or other related experience
Sr Manager Minimum Education & Experience Requirements:
Bachelor's degree
8+ years of pharmaceutical/biotech/medical device sales experience, or other related experience
2+ years prior training experience
Preferred Skills and Knowledge Qualifications:
Experience selling injectables and/or physician administered treatments in challenging reimbursement environments
Experience selling in the Psychiatry or Addiction markets
Building & executing training programs
Experience in utilizing technology to engage field groups
Demonstrated track record of success in sales
Proven ability to create, develop & lead projects
High level of initiative and ownership
Demonstrated ability to work independently
Exceptional communication, facilitation, and presentation skills
In-depth understanding of sales & the sales process
Team player able to develop rapport and credibility with key stakeholders
Natural ability to flex & adapt in real time based on multiple channels of feedback
Proficiency in Microsoft PowerPoint
Travel Requirements:
Up to 60% travel
The annual base salary for this position ranges from $148k to $170k. In addition, this position is eligible for an annual performance pay bonus. Exact compensation may vary based on skills, training, knowledge, and experience. Alkermes offers a competitive benefits package. Additional details can be found on our careers website: www.alkermes.com/careers#working-here
#LI-TT1 #LI-hybrid
Why join Team Alkermes?
Alkermes applies its deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders. A fully-integrated, global biopharmaceutical company, headquartered in Ireland with U.S. locations in Massachusetts and Ohio, we are committed to pursuing great science, driven by deep compassion to make a real impact in the lives of patients. Alkermes has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for various neurological disorders, including narcolepsy.
Beyond our important mission of developing medicines to address unmet patient needs, we actively seek to foster a culture of diversity, inclusion and belonging throughout our business. We strive to ensure that all voices are respected and valued, recognizing that our diversity of thought, background and perspective makes us stronger. We are proud to have been recognized as an employer of choice by many national organizations, including being certified as a Great Place to Work in the U.S. in 2024, honored as a Healthiest Employer in both Ohio and Massachusetts in 2023, a Best Place for Working Parents in 2023, and to have received the Bell Seal at the Platinum level for Workplace Mental Health by Mental Health America for three consecutive years (2021-2023).
Alkermes, Inc. is an equal employment opportunity employer and does not discriminate against any qualified applicant or employee because of race, creed, color, age, national origin, ancestry, religion, gender, sexual orientation, gender expression and identity, disability, genetic information, veteran status, military status, application for military service or any other characteristic protected by local, state or federal law. Alkermes also complies with all work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Alkermes is an E-Verify employer.
At Alkermes, we apply our deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders. We have a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for neurological disorders. Our patient-inspired science, integrated research strategy, sophisticated development capabilities and specialized commercial infrastructure enable us to pursue the development and commercialization of innovative new medicines, including those for people with conditions that have traditionally been overlooked or stigmatized.
Our greatest strengths at Alkermes are our people and our inherent empathy for patients, families and caregivers. Neurological and psychiatric disorders strike people at the core of who they are and impact many facets of their lives. We work with urgency to develop new treatment options for people living with these conditions.
Beyond our important mission of developing medicines, we believe it is our responsibility to take a holistic approach as we seek to support patients, caregivers and broader impacted communities. We remain committed to patient engagement, responsible and sustainable operations, and equitable access to quality treatment.
Headquartered in Ireland, Alkermes also has a corporate office and research and development center in Massachusetts and a manufacturing facility in Ohio.
See our Community Guidelines: https://www.alkermes.com/social-community-guidelines
